YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
Swiss health care company Novartis has made a tender offer to acquire German cancer drugmaker MorphoSys.
Novartis is offering $73 per share, a premium of around 142%.
Novartis also recently announced it's pausing enrollment of new patients in clinical trials for Kisqali, a breast cancer treatment.
Read more from Quartz.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Banker pleads guilty to fraud scheme
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects